ALB and neoplasm: The assessment of other potentially important indicators of tumor progression and survival outcomes in lung cancer patients (e.g., modified Glasgow prognostic score, C-reactive protein to albumin ratio, prognostic nutrition index, pretreatment advanced lung cancer inflammation index, and procalcitonin) were considered to be beyond the scope of the current study but ideally would be included in future comparative analyses [79].